Drug management of obesity--efficacy versus safety

N Engl J Med. 2010 Jul 15;363(3):288-90. doi: 10.1056/NEJMe1004076.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anti-Obesity Agents / adverse effects*
  • Anti-Obesity Agents / therapeutic use*
  • Benzazepines / adverse effects
  • Benzazepines / therapeutic use*
  • Contraindications
  • Cyclobutanes
  • Drug Approval / legislation & jurisprudence
  • Fenfluramine / adverse effects
  • Humans
  • Obesity / drug therapy*
  • Overweight / drug therapy
  • Serotonin 5-HT2 Receptor Agonists*
  • Serotonin Receptor Agonists / therapeutic use*
  • United States
  • United States Food and Drug Administration
  • Weight Loss / drug effects

Substances

  • Anti-Obesity Agents
  • Benzazepines
  • Cyclobutanes
  • Serotonin 5-HT2 Receptor Agonists
  • Serotonin Receptor Agonists
  • Fenfluramine
  • lorcaserin
  • sibutramine